Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) EBITDA Margin (2022 - 2023)

Vycor Medical (VYCO) has disclosed EBITDA Margin for 6 consecutive years, with 16.82% as the latest value for Q3 2023.

  • Quarterly EBITDA Margin rose 2022.0% to 16.82% in Q3 2023 from the year-ago period, while the trailing twelve-month figure was 7.94% through Sep 2023, up 5452.0% year-over-year, with the annual reading at 211.32% for FY2012, 24849.0% up from the prior year.
  • EBITDA Margin for Q3 2023 was 16.82% at Vycor Medical, down from 14.17% in the prior quarter.
  • The five-year high for EBITDA Margin was 14.17% in Q2 2023, with the low at 37.04% in Q3 2022.